Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 23, 2022
Patent Application Number
17397713
Date Filed
August 9, 2021
Patent Primary Examiner
Disclosed herein include microRNA antagonists, therapeutic compositions that include one or more of such microRNA antagonists, and methods of treating and/or ameliorating cardiac diseases and/or muscular dystrophy disorders with the microRNA antagonists. Also included are combination therapies, wherein a therapeutic composition disclosed herein and an additional therapy agent are provided to a subject having or suspected of having cardiac disease and/or muscular dystrophy disorder. In particular, some embodiments disclosed herein relate to compositions and methods for transiently administering a mixture of microRNA antagonists for promoting cardiomyocyte proliferation and cardiac regeneration.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.